1. Home
  2. Pharma & Healthcare
  3. Global Paclitaxel Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Paclitaxel Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 136 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global Paclitaxel market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Paclitaxel market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Paclitaxel in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Natural Paclitaxel API
Semi-synthetic Paclitaxel API

Market Snapshot, By Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
Yunnan Hande
TAPI (Teva)
Southpharma
ScinoPharm
Samyang
Polymed
Phyton
Novasep
Jiangsu Yew Biotechnology
Huiang biopharma
Hainan Yew Pharm
Fresenius-kabi

The study objectives of this report are:
To study and analyze the global Paclitaxel market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Paclitaxel market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Paclitaxel manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Paclitaxel market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Paclitaxel submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Paclitaxel are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Paclitaxel Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Paclitaxel Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Paclitaxel

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Paclitaxel Sales Channel and Distributors Analysis
3.3.1 Paclitaxel Sales Channel
3.3.2 Paclitaxel Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Paclitaxel Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Paclitaxel Type Introduction
4.1.1 Natural Paclitaxel API
4.1.2 Semi-synthetic Paclitaxel API
4.2 Global Paclitaxel Sales by Type 2016-2021
4.3 Global Paclitaxel Revenue by Type 2016-2021
4.4 Global Paclitaxel Price by Type 2016-2021

5 Market Segment: by Application
5.1 Paclitaxel Type Introduction
5.1.1 Ovarian Cancer
5.1.2 Cervical Cancer
5.1.3 Breast Cancer
5.1.3 Other
5.2 Global Paclitaxel Sales by Application 2016-2021
5.3 Global Paclitaxel Revenue by Application 2016-2021
5.4 Global Paclitaxel Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Paclitaxel Market by Region
6.1.1 Global Paclitaxel Sales by Regions
6.1.2 Global Paclitaxel Revenue by Regions
6.2 North America Paclitaxel Market 2016-2021
6.3 Europe Paclitaxel Market 2016-2021
6.4 Asia Pacific Paclitaxel Market 2016-2021
6.5 South America Paclitaxel Market 2016-2021
6.6 Middle East and Africa Paclitaxel Market 2016-2021

7 North America
7.1 North America Paclitaxel Market by Country 2016-2021
7.1.1 North America Paclitaxel Sales by Country
7.1.2 North America Paclitaxel Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Paclitaxel Market by Country 2016-2021
8.1.1 Europe Paclitaxel Sales by Country
8.1.2 Europe Paclitaxel Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Paclitaxel Market by Country 2016-2021
9.1.1 Asia Pacific Paclitaxel Sales by Country
9.1.2 Asia Pacific Paclitaxel Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Paclitaxel Market by Country 2016-2021
10.1.1 South America Paclitaxel Sales by Country
10.1.2 South America Paclitaxel Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Paclitaxel Market by Country 2016-2021
11.1.1 Middle East and Africa Paclitaxel Sales by Country
11.1.2 Middle East and Africa Paclitaxel Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Yunnan Hande
12.1.1 Yunnan Hande Company Information
12.1.2 Yunnan Hande Paclitaxel Product Portfolio, Specification and Application
12.1.3 Yunnan Hande Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Yunnan Hande Key Development
12.2 TAPI (Teva)
12.2.1 TAPI (Teva) Company Information
12.2.2 TAPI (Teva) Paclitaxel Product Portfolio, Specification and Application
12.2.3 TAPI (Teva) Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 TAPI (Teva) Key Development
12.3 Southpharma
12.3.1 Southpharma Company Information
12.3.2 Southpharma Paclitaxel Product Portfolio, Specification and Application
12.3.3 Southpharma Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Southpharma Key Development
12.4 ScinoPharm
12.4.1 ScinoPharm Company Information
12.4.2 ScinoPharm Paclitaxel Product Portfolio, Specification and Application
12.4.3 ScinoPharm Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 ScinoPharm Key Development
12.5 Samyang
12.5.1 Samyang Company Information
12.5.2 Samyang Paclitaxel Product Portfolio, Specification and Application
12.5.3 Samyang Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Samyang Key Development
12.6 Polymed
12.6.1 Polymed Company Information
12.6.2 Polymed Paclitaxel Product Portfolio, Specification and Application
12.6.3 Polymed Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Polymed Key Development
12.7 Phyton
12.7.1 Phyton Company Information
12.7.2 Phyton Paclitaxel Product Portfolio, Specification and Application
12.7.3 Phyton Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Polymed Key Development
12.9 Jiangsu Yew Biotechnology
12.9.1 Jiangsu Yew Biotechnology Company Information
12.9.2 Jiangsu Yew Biotechnology Paclitaxel Product Portfolio, Specification and Application
12.9.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Jiangsu Yew Biotechnology Key Development
12.8 Novasep
12.8.1 Novasep Company Information
12.8.2 Novasep Paclitaxel Product Portfolio, Specification and Application
12.8.3 Novasep Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Novasep Key Development
12.11 Hainan Yew Pharm
12.11.1 Hainan Yew Pharm Company Information
12.11.2 Hainan Yew Pharm Paclitaxel Product Portfolio, Specification and Application
12.11.3 Hainan Yew Pharm Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Hainan Yew Pharm Key Development
12.12 Fresenius-kabi
12.12.1 Fresenius-kabi Company Information
12.12.2 Fresenius-kabi Paclitaxel Product Portfolio, Specification and Application
12.12.3 Fresenius-kabi Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Fresenius-kabi Key Development

13 Global Paclitaxel Market Forecast by Region by Type and by Application
13.1 Global Paclitaxel Sales, Revenue Forecast 2022-2027
13.2 Global Paclitaxel Forecast by Regions
13.2.1 Global Paclitaxel Sales Forecast by Region 2022-2027
13.2.2 Global Paclitaxel Revenue Forecast by Region 2022-2027
13.3 Global Paclitaxel Forecast by Type
13.3.1 Global Paclitaxel Sales Forecast by Type 2022-2027
13.3.2 Global Paclitaxel Revenue Forecast by Type 2022-2027
13.3.3 Global Paclitaxel Price Forecast by Type 2022-2027
13.4 Global Paclitaxel Forecast by Application
13.4.1 Global Paclitaxel Sales Forecast by Application 2022-2027
13.4.2 Global Paclitaxel Revenue Forecast by Application 2022-2027
13.4.3 Global Paclitaxel Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global Paclitaxel Production Specifications
Table 2: Drivers in Paclitaxel Market
Table 3: Restraints Paclitaxel Market
Table 4: Opportunity in Paclitaxel Market
Table 5: Comparion of Alternative and Paclitaxel
Table 6: Paclitaxel Raw Materials Key Suppliers List
Table 7: Paclitaxel Distributors List
Table 8: Paclitaxel Major Buyers in Application One
Table 9: Paclitaxel Major Buyers in Application Two
Table 10: Paclitaxel Major Buyers in Application Three
Table 11: Global Paclitaxel Sales (K Units) by Type 2016-2021
Table 12: Global Paclitaxel Sales Market Share by Type 2016-2021
Table 13: Global Paclitaxel Revenue (Million USD) by Type 2016-2021
Table 14: Global Paclitaxel Revenue Market Share by Type 2016-2021
Table 15: Global Paclitaxel Price by Type 2016-2021
Table 16: Global Paclitaxel Sales (K Units) by Application 2016-2021
Table 17: Global Paclitaxel Sales Market Share by Application 2016-2021
Table 18: Global Paclitaxel Revenue (Million USD) by Application 2016-2021
Table 19: Global Paclitaxel Revenue Market Share by Application 2016-2021
Table 20: Global Paclitaxel Price by Application 2016-2021
Table 21: Global Paclitaxel Sales (K Units) by Region 2016-2021
Table 22: Global Paclitaxel Sales Market Share by Region 2016-2021
Table 23: Global Paclitaxel Revenue (Million USD) by Region 2016-2021
Table 24: Global Paclitaxel Revenue Market Share by Region 2016-2021
Table 25: North America Paclitaxel Sales (K Units) by Country 2016-2021
Table 26: North America Paclitaxel Sales Market Share by Country 2016-2021
Table 27: North America Paclitaxel Revenue (Million USD) by Country 2016-2021
Table 28: North America Paclitaxel Revenue Market Share by Country 2016-2021)
Table 29: Europe Paclitaxel Sales (K Units) by Country 2016-2021
Table 30: Europe Paclitaxel Sales Market Share by Country 2016-2021
Table 31: Europe Paclitaxel Revenue (Million USD) by Country 2016-2021
Table 32: Europe Paclitaxel Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Paclitaxel Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Paclitaxel Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Paclitaxel Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Paclitaxel Revenue Market Share by Country 2016-2021)
Table 37: South America Paclitaxel Sales (K Units) by Country 2016-2021
Table 38: South America Paclitaxel Sales Market Share by Country 2016-2021
Table 39: South America Paclitaxel Revenue (Million USD) by Country 2016-2021
Table 40: South America Paclitaxel Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Paclitaxel Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Paclitaxel Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Paclitaxel Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Paclitaxel Revenue Market Share by Country 2016-2021)
Table 45 Yunnan Hande Company Information
Table 46 Yunnan Hande Paclitaxel Product Portfolio, Specification and Application
Table 47 Yunnan Hande Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 TAPI (Teva) Company Information
Table 49 TAPI (Teva) Paclitaxel Product Portfolio, Specification and Application
Table 50 TAPI (Teva) Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Southpharma Company Information
Table 52 Southpharma Paclitaxel Product Portfolio, Specification and Application
Table 53 Southpharma Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 ScinoPharm Company Information
Table 55 ScinoPharm Paclitaxel Product Portfolio, Specification and Application
Table 56 ScinoPharm Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Samyang Company Information
Table 58 Samyang Paclitaxel Product Portfolio, Specification and Application
Table 59 Samyang Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Polymed Company Information
Table 61 Polymed Paclitaxel Product Portfolio, Specification and Application
Table 62 Polymed Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Phyton Company Information
Table 64 Phyton Paclitaxel Product Portfolio, Specification and Application
Table 65 Phyton Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Novasep Company Information
Table 67 Novasep Paclitaxel Product Portfolio, Specification and Application
Table 68 Novasep Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Jiangsu Yew Biotechnology Company Information
Table 70 Jiangsu Yew Biotechnology Paclitaxel Product Portfolio, Specification and Application
Table 71 Jiangsu Yew Biotechnology Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Paclitaxel Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Paclitaxel Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Paclitaxel Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Paclitaxel Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Paclitaxel Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Paclitaxel Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Paclitaxel Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Paclitaxel Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Paclitaxel Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Paclitaxel Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Paclitaxel Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Paclitaxel Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: Paclitaxel Picture
Figure 2: Global Paclitaxel Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Paclitaxel Supply Chain Analysis
Figure 5: Paclitaxel Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Natural Paclitaxel API
Figure 7: Product Picture of Semi-synthetic Paclitaxel API
Figure 8: Global Paclitaxel Sales Market Share by Type, 2020
Figure 9: Global Paclitaxel Revenue Market Share by Type, 2020
Figure 10: Paclitaxel in Ovarian Cancer
Figure 11: Global Paclitaxel Market: Ovarian Cancer 2016-2021
Figure 12: Paclitaxel in Cervical Cancer
Figure 13: Global Paclitaxel Market: Cervical Cancer 2016-2021
Figure 14: Global Paclitaxel Sales Market Share by Application, 2020
Figure 15: Global Paclitaxel Revenue Market Share by Application, 2020
Figure 16: Global Paclitaxel Sales Market Share by Region 2016-2021
Figure 17: Global Paclitaxel Revenue Market Share by Region 2016-2021
Figure 18: North America Paclitaxel Sales (K Units) Status 2016-2021
Figure 19: North America Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 20: Europe Paclitaxel Sales (K Units) Status 2016-2021
Figure 21: Europe Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Paclitaxel Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 24: South America Paclitaxel Sales (K Units) Status 2016-2021
Figure 25: South America Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Paclitaxel Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 28: North America Paclitaxel Sales Market Share by Country, 2020
Figure 29: North America Paclitaxel Revenue Market Share by Country, 2020
Figure 30: United States Paclitaxel Sales (K Units) Status 2016-2021
Figure 31: United States Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 32: Canada Paclitaxel Sales (K Units) Status 2016-2021
Figure 33: Canada Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Paclitaxel Sales (K Units) Status 2016-2021
Figure 35: Mexico Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 36: Europe Paclitaxel Sales Market Share by Country, 2020
Figure 37: Europe Paclitaxel Revenue Market Share by Country, 2020
Figure 38: Germany Paclitaxel Sales (K Units) Status 2016-2021
Figure 39: Germany Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 40: France Paclitaxel Sales (K Units) Status 2016-2021
Figure 41: France Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 42: UK Paclitaxel Sales (K Units) Status 2016-2021
Figure 43: UK Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 44: Italy Paclitaxel Sales (K Units) Status 2016-2021
Figure 45: Italy Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 46: Russia Paclitaxel Sales (K Units) Status 2016-2021
Figure 46: Russia Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 47: Spain Paclitaxel Sales (K Units) Status 2016-2021
Figure 48: Spain Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Paclitaxel Sales Market Share by Country, 2020
Figure 50: Asia Pacific Paclitaxel Revenue Market Share by Country, 2020
Figure 51: China Paclitaxel Sales (K Units) Status 2016-2021
Figure 52: China Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 53: Japan Paclitaxel Sales (K Units) Status 2016-2021
Figure 54: Japan Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 55: Korea Paclitaxel Sales (K Units) Status 2016-2021
Figure 56: Korea Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Paclitaxel Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 59: India Paclitaxel Sales (K Units) Status 2016-2021
Figure 60: India Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 61: Australia Paclitaxel Sales (K Units) Status 2016-2021
Figure 62: Australia Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 63: South America Paclitaxel Sales Market Share by Country, 2020
Figure 64: South America Paclitaxel Revenue Market Share by Country, 2020
Figure 65: Brazil Paclitaxel Sales (K Units) Status 2016-2021
Figure 66: Brazil Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Paclitaxel Sales (K Units) Status 2016-2021
Figure 68: Argentina Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Paclitaxel Sales (K Units) Status 2016-2021
Figure 70: Colombia Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Paclitaxel Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Paclitaxel Revenue Market Share by Country, 2020
Figure 73: Turkey Paclitaxel Sales (K Units) Status 2016-2021
Figure 74: Turkey Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Paclitaxel Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Paclitaxel Sales (K Units) Status 2016-2021
Figure 78: South Africa Paclitaxel Revenue (Million USD) Status 2016-2021
Figure 79: Yunnan Hande Paclitaxel Revenue Market Share Globally (2019-2021)
Figure 80: TAPI (Teva) Paclitaxel Revenue Market Share Globally (2019-2021)
Figure 81: Southpharma Paclitaxel Revenue Market Share Globally (2019-2021)
Figure 82: ScinoPharm Paclitaxel Revenue Market Share Globally (2019-2021)
Figure 83: Samyang Paclitaxel Revenue Market Share Globally (2019-2021)
Figure 84: Polymed Paclitaxel Revenue Market Share Globally (2019-2021)
Figure 85: Phyton Paclitaxel Revenue Market Share Globally (2019-2021)
Figure 86: Novasep Paclitaxel Revenue Market Share Globally (2019-2021)
Figure 87: Jiangsu Yew Biotechnology Paclitaxel Revenue Market Share Globally (2019-2021)
Figure 88: Huiang biopharma Paclitaxel Revenue Market Share Globally (2019-2021)
Figure 89: Global Paclitaxel Sales (K Units) Forecast (2022-2027)
Figure 90: Global Paclitaxel Sales (K Units) Forecast (2022-2027)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets